Shining light on the significance of NK cell CD56 brightness

被引：28
|
作者：
Poznanski, Sophie M. [1 ]
Ashkar, Ali A. [1 ,2 ]
机构：
[1] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada
[2] McMaster Univ, 1280 Main St West,MDCL 4015, Hamilton, ON, Canada
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2018年 / 15卷 / 12期
关键词：
CANCER-PATIENTS;
D O I：
10.1038/s41423-018-0163-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1071 / 1073
页数：3
相关论文
共 50 条
  • [1] Shining light on the significance of NK cell CD56 brightness
    Sophie M. Poznanski
    Ali A. Ashkar
    Cellular & Molecular Immunology, 2018, 15 : 1071 - 1073
  • [2] Oncolytic virus treatment differentially affects the CD56(dim) and CD56(bright) NK cell subsets in vivo and regulates a spectrum of human NK cell activity
    Wantoch, Michelle
    Wilson, Erica B.
    Droop, Alastair P.
    Phillips, Sarah L.
    Coffey, Matt
    El-Sherbiny, Yasser M.
    Holmes, Tim D.
    Melcher, Alan A.
    Wetherill, Laura F.
    Cook, Graham P.
    IMMUNOLOGY, 2022, 166 (01) : 104 - 120
  • [3] CD56(+BRIGHT) BUT NOT CD56(+DIM) NATURAL-KILLER-CELL (NK), SUBSETS EXHIBIT CONTACT-MEDIATED PROLIFERATION
    PIERSON, BA
    MCGLAVE, PB
    HU, WS
    MILLER, JS
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 836 - 836
  • [4] Chicken CD56 defines NK cell subsets in embryonic spleen and lung
    Neulen, Marie-Luise
    Goebel, Thomas W.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2012, 38 (03): : 410 - 415
  • [5] CD56(+) NK lymphomas: Clinicopathological features and prognosis
    Kwong, YL
    Chan, ACL
    Liang, R
    Chiang, AKS
    Chim, CS
    Chan, TK
    Todd, D
    Ho, FCS
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) : 821 - 829
  • [6] Prognostic significance of perioperative circulating CD56 bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery
    You, Jeng-Fu
    Lee, Cheng-Chi
    Lee, Yun-Shien
    Chern, Yih-Jong
    Liao, Chun-Kai
    Hsu, Hung-Chih
    TRANSLATIONAL ONCOLOGY, 2025, 52
  • [7] CD56 regulates human NK cell cytotoxicity through Pyk2
    Gunesch, Justin T.
    Dixon, Amera L.
    Ebrahim, Tasneem A. M.
    Berrien-Elliott, Melissa M.
    Tatineni, Swetha
    Kumar, Tejas
    Hegewisch-Solloa, Everardo
    Fehniger, Todd A.
    Mace, Emily M.
    ELIFE, 2020, 9 : 1 - 28
  • [8] CD56
    Warren, HS
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2000, 14 (04): : 317 - 321
  • [9] Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression
    Junge, Alexandra
    Bacher, Ulrike
    Mueller, Beatrice U.
    Keller, Peter
    Solenthaler, Max
    Pabst, Thomas
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 576 - 583
  • [10] Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression
    Junge, A.
    Bacher, U.
    Keller, P.
    Mueller, B. U.
    Solenthaler, M.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2018, 148 : 8S - 9S
12345